Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: Suppression of NF-κB activation and MAPK signaling

被引:46
作者
Lee, Hyeong-Seon [2 ]
Ryu, Deok-Seon [2 ]
Lee, Gyeong-Seon [2 ]
Lee, Dong-Seok [1 ,2 ]
机构
[1] Inje Univ, Dept Smart Foods & Drugs, Grad Sch, Gimhae 621749, Gyeongnam, South Korea
[2] Inje Univ, Dept Biomed Lab Sci, Gimhae 621749, Gyeongnam, South Korea
关键词
Orostachys japonicas; Anti-inflammatory effects; MAPKs; NF-kappa B; RAW; 264.7; cells; NITRIC-OXIDE SYNTHASE; RAW-264.7; MACROPHAGES; POSSIBLE INVOLVEMENT; DOWN-REGULATION; EXPRESSION; INOS; INHIBITION; INDUCTION; EXTRACT; COX-2;
D O I
10.1016/j.jep.2012.01.016
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Orostachys japonicus A. Berger (O. japonicus) is known to reduce the risk of many diseases. Aim of the study: We investigated the anti-inflammatory effects of the dichloromethane (DCM) fraction from O. japonicus (OJD) in LPS-stimulated RAW 264.7 cells. Materials and methods: NO was measured using the Griess method. Key pro-inflammatory cytokines and mediators including IL-1 beta, TLR4, iNOS, and COX-2; 2 important pro-inflammatory transcription factors, NF-kappa B p65 and tact; and MAPKs such as ERK1/2, JNK, and p38 were analyzed by Western blotting. Results: OJD significantly inhibited NO production, IL-1 beta. TLR4, iNOS, and COX-2 expression in LPS-stimulated cells. Additionally, it inhibited LPS-induced NF-kappa B p65 activation via inhibition of I kappa B alpha. phosphorylation. Furthermore, phosphorylation of p38 and JNK was suppressed by OJD in a dose-dependent manner in the LPS-stimulated RAW 264.7 cells. Conclusions: Our data suggest that OJD inhibits the inflammatory response via suppression of NF-kappa B activation and MAPK signaling. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:271 / 276
页数:6
相关论文
共 31 条
[1]   Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-KB activation in RAW 264.7 cells [J].
Ahn, KS ;
Noh, EJ ;
Zhao, HL ;
Jung, SH ;
Kang, SS ;
Kim, YS .
LIFE SCIENCES, 2005, 76 (20) :2315-2328
[2]  
Bak Min Ji, 2009, Preventive Nutrition and Food Science, V14, P269
[3]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[4]   Automated High-Throughput siRNA Transfection in Raw 264.7 Macrophages: A Case Study for Optimization Procedure [J].
Carralot, Jean-Philippe ;
Kim, Tae-Kyu ;
Lenseigne, Boris ;
Boese, Annette S. ;
Sommer, Peter ;
Genovesio, Auguste ;
Brodin, Priscille .
JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (02) :151-160
[5]   NF-κB signalling: Embracing complexity to achieve translation [J].
Chakraborty, Jayashree Bagchi ;
Mann, Derek A. .
JOURNAL OF HEPATOLOGY, 2010, 52 (02) :285-291
[6]   Inhibitory effects of Orostachys japonicus extracts on the formation of N-nitrosodimethylamine [J].
Choi, Sun Young ;
Chung, Mi Ja ;
Seo, Woo Duck ;
Shin, Jung Hye ;
Shon, Mi Yae ;
Sung, Nak Ju .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2006, 54 (16) :6075-6078
[7]  
Choi YE, 2000, BIOL PHARM BULL, V23, P884, DOI 10.1248/bpb.23.884
[8]   Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-κB activation [J].
Chun, KS ;
Keum, YS ;
Han, SS ;
Song, YS ;
Kim, SH ;
Surh, YJ .
CARCINOGENESIS, 2003, 24 (09) :1515-1524
[9]   Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex [J].
Frobose, Helle ;
Ronn, Sif Groth ;
Heding, Peter E. ;
Mendoza, Heidi ;
Cohen, Philip ;
Mandrup-Poulsen, Thomas ;
Billestrup, Nils .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (07) :1587-1596
[10]   Tanshinone IIA inhibits LPS-induced NF-κB activation in RAW 264.7 cells:: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways [J].
Jang, Seon ;
Kim, Hyung Jin ;
Kim, Young-Jun ;
Jeong, Seung-Il ;
You, Yong-Ouk .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 542 (1-3) :1-7